Navellier & Associates’s Allergan plc AGN Stock Holding History

Navellier & Associates’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-91,886	Closed	-$25M	–	324
2015 Q3	$25M	Sell	91,886 -54,545	-37%	-$16.8M	2.51%	10
2015 Q2	$44.4M	Buy	146,431 +607	+0.4%	+$181K	3.9%	1
2015 Q1	$43.4M	Sell	145,824 -175,549	-55%	-$50M	3.94%	1
2014 Q4	$82.7M	Sell	321,373 -21,591	-6%	-$5.4M	4.13%	2
2014 Q3	$82.8M	Sell	342,964 -43,197	-11%	-$9.67M	4.16%	2
2014 Q2	$86.1M	Sell	386,161 -12,052	-3%	-$2.5M	3.9%	2
2014 Q1	$82M	Sell	398,213 -20,389	-5%	-$4.04M	3.82%	2
2013 Q4	$70.3M	Sell	418,602 -45,649	-10%	-$7.14M	3.17%	5
2013 Q3	$66.9M	Buy	464,251 +80,653	+21%	+$10.7M	1.97%	9
2013 Q2	$48.4M	Buy	+383,598	New	+$43.4M	2.31%	14

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Navellier & Associates's AGN Position: Q4 2015 in Review

Navellier & Associates sold out of Allergan plc (AGN) in Q4 2015, closing a stake of 91,886 shares — an estimated $25M sold.

Navellier & Associates first reported a position in AGN in Q2 2013 and held it in 10 quarters. The position peaked at $86.1M in Q2 2014. 1,110 funds tracked by Wall St. Rank hold AGN as of Q4 2015.

Navellier & Associates reported no remaining Allergan plc position as of Q4 2015 after selling out during the quarter.
Navellier & Associates sold 91,886 Allergan plc shares in Q4 2015, an estimated $25M.
Navellier & Associates first reported a position in Allergan plc in Q2 2013 and held it in 10 quarters.
Navellier & Associates's Allergan plc position peaked at $86.1M in Q2 2014.
1,110 funds tracked by Wall St. Rank held Allergan plc as of Q4 2015.

Based on Navellier & Associates's 13F filing for Q4 2015, filed 10 Feb 2016.